Show simple item record

dc.contributor.authorJohansson, Hanna Katarina Lilith
dc.contributor.authorSvingen, Terje
dc.contributor.authorBoberg, Julie
dc.contributor.authorFowler , Paul A
dc.contributor.authorStead, David
dc.contributor.authorVinggaard, Anne Marie
dc.contributor.authorFilis, Panagiotis
dc.date.accessioned2020-05-20T07:20:03Z
dc.date.available2020-05-20T07:20:03Z
dc.date.issued2020-04
dc.identifier.citationJohansson , H K L , Svingen , T , Boberg , J , Fowler , P A , Stead , D , Vinggaard , A M & Filis , P 2020 , ' Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat ' , Archives of Toxicology , vol. 94 , pp. 1241-1250 . https://doi.org/10.1007/s00204-020-02697-3en
dc.identifier.issn0340-5761
dc.identifier.otherPURE: 158359947
dc.identifier.otherPURE UUID: 26e94702-63f6-4365-b76f-84d1865ff501
dc.identifier.otherPubMed: 32221642
dc.identifier.otherWOS: 000521900800001
dc.identifier.otherSCOPUS: 85082429722
dc.identifier.otherScopus: 85082429722
dc.identifier.otherORCID: /0000-0001-9268-5868/work/76974325
dc.identifier.otherORCID: /0000-0002-4831-9075/work/79059739
dc.identifier.urihttps://hdl.handle.net/2164/14335
dc.descriptionOpen Access via Springer Compact Acknowledgements This work was funded by the Ministry of Environment and Food of Denmark, and by a grant from the European Commission 7th Framework Program CONTAMED (Contaminant mixtures and human reproductive health-novel strategies for health impact and risk assessment of endocrine disrupters, grant agreement no.: 215202), as well as the Medical Research Council (UK) (MR/L010011/1 to PAF) and the EU Horizon 2020 project FREIA (Grant Number 825100). We would like to thank Heidi Letting, the Animal facilities at DTU food, and the University of Aberdeen Proteomics Core Facility for their support and assistance in this work.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofArchives of Toxicologyen
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectovaryen
dc.subjectproteomeen
dc.subjectendocrine disruptoren
dc.subjectcalretininen
dc.subjectOvarian Dysgenesis Syndromeen
dc.subjectAOPen
dc.subjectCalretininen
dc.subjectOvarian dysgenesis syndromeen
dc.subjectEndocrine disruptionen
dc.subjectProteomeen
dc.subjectFEMALEen
dc.subjectOvaryen
dc.subjectCHEMICALSen
dc.subjectINTRAUTERINEen
dc.subjectOUTCOME PATHWAYSen
dc.subjectMENOPAUSEen
dc.subjectEXPRESSIONen
dc.subjectPROTEOMICSen
dc.subjectAGEen
dc.subjectR Medicineen
dc.subjectHealth, Toxicology and Mutagenesisen
dc.subjectToxicologyen
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/L010011/1en
dc.subjectEuropean Commissionen
dc.subject215202en
dc.subject825100en
dc.subjectSupplementary data availableen
dc.subject.lccRen
dc.titleCalretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the raten
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Biological Sciences (Research Theme)en
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1007/s00204-020-02697-3
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85082429722&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record